SCIENTIFIC PROGRAMME
Sunday, May 16, 2004, 08.00 - 08.45
Fernando Valderrábano Memorial Lecture
The many
problems of kidney transplantation.
Chair: F. Locatelli, Lecco, Italy and F. Carrera,
Lisbon, Portugal
C. Ponticelli, Milan, Italy
Monday, May 17, 2004, 08.00 - 08.45
Renal phosphate
handling in health and disease: a molecular view.
Chair: V. Cambi, Parma, Italy and T. Drüeke,
Paris, France
H. Murer, Zurich, Switzerland
Tuesday, May 18, 2004, 08.00 - 08.45
The promise
of BMP-7 therapy in chronic kidney disease.
Chair: K. Olgaard, Copenhagen, Denmark and L. Guerra,
Porto, Portugal
K. Hruska,
Saint Louis, USA
Sunday, May 16, 2004, 17.40
– 18.10
The effects of silent AV graft infection in EPO-resistant anaemia.
J.C. Ayus, Houston, USA
Sunday, May 16, 2004, 17.40
– 18.10
Genetic and molecular changes in the refractory secondary hyperparathyroidism.
J. Cannata-Andía, Oviedo, Spain
Sunday, May 16, 2004, 17.40
– 18.10
Arteriosclerosis in uraemic patients – what is new in pathogenesis
and treatment in 2004.
A. Wiecek, Katowice, Poland
Sunday, May 16, 2004, 17.40
– 18.10
Sudden cardiac death in ESRD.
M. Valderrábano, Los Angeles, USA
Monday,
May 17, 2004, 17.10 – 17.40
Linking pathogenesis of vasculitis to informed therapy.
C.O.S. Savage, Birmingham, United Kingdom
Monday,
May 17, 2004, 17.10 – 17.40
New insights into the pathophysiology of glomerular diseases: from bedside
to bench.
P. Ronco, Paris, France
Monday, May 17,
2004, 17.10 – 17.40
Post transplant bone disease.
K. Olgaard, Copenhagen, Denmark
Monday, May 17,
2004, 17.10 – 17.40
Renal anaemia management: What’s new in 2004?
I.C. Macdougall, London, United Kingdom
Sunday,
May 16, 2004, 09.00 – 10.30
1. Calcimimetics. From basic science to clinical application: a new
treatment of secondary hyperparathyroidism.
Chairman Emeritus: Jack W. Coburn,† Professor of Medicine, UCLA, USA
Chair: W.G. Goodman, Los Angeles, USA and J. Cannata-Andía,
Oviedo, Spain
- Regulation of
parathyroid function by calcimimetic compounds
E. Nemeth, Toronto, Canada
- Clinical trials justifying use of a calcimimetic agent
J. Frazão, Porto, Portugal
- Calcimimetics: How and when we should use them
W.G. Goodman, Los Angeles, USA
Sunday, May 16, 2004, 09.00 – 10.30
2. Evidence based nephrology.
Chair: A. MacLeod, Aberdeen, United Kingdom and A.
Vaz Carneiro, Lisbon, Portugal
- Evidence Based
Nephrology: what it is and what it isn’t
A. MacLeod, Aberdeen, United Kingdom
- Critical appraisal of a therapeutics article: basic rules
A. Vaz Carneiro, Lisbon, Portugal
- Evidence-based diagnosis
A. Knottnerus, Maastricht, the Netherlands
Sunday, May 16, 2004, 09.00 – 10.30
3. Growth factors in renal disease.
Chair: P. Ronco, Paris, France and F.P. Schena,
Bari, Italy
- Connective tissue
growth factors
R. Goldschmeding, Utrecht, the Netherlands
- Novel platelet derived growth factors: PDGF-CC and PDGF-DD
F. Eitner, Aachen, Germany
- VEGF, angiopoietins and intrarenal angiogenesis
P. Mathieson, Bristol, United Kingdom
Sunday, May 16, 2004, 13.30 – 15.00
4. Diabetes Revisited.
Chair: E. Ritz, Heidelberg, Germany and R. Romero,
Barcelona, Spain
- Insights into
the molecular mechanisms of diabetes induced organ damage
G. Wolf, Hamburg, Germany
- Cardiac changes in diabetes melitus: new insights into their genesis and management
E. Standl, Munich, Germany
- Management of diabetic nephropathy - what is new?
E. Ritz, Heidelberg, Germany
Discussion: When to start dialysis in the diabetic patient.
Sunday, May 16, 2004, 13.30 – 15.00
5. From guidelines to daily clinical care.
Chair: F. Locatelli, Lecco, Italy and M. Prata,
Lisbon, Portugal
- Gambro database
J. Bosch, Washington, USA
- Fresenius Medical Care database
D. Marcelli, Bad Homburg, Germany
- Kuratorium database
C. Baldamus, Cologne, Germany
Sunday, May 16, 2004, 13.30 – 15.00
6. Clinicopathological correlates in the nephrotic syndrome.
(European Kidney Research Association)
Chair: J.J. Weening, Amsterdam, the Netherlands and
L.H. Noel, Paris, France
- Hereditary/congenital
nephrotic syndrome
M.C. Gubler, Paris, France
- Podocyte biology – current insights
P. Mathieson, Bristol, United Kingdom
- Etiology and pathogenesis of minimal change nephrotic syndrome and focal segmental
glomerulosclerosis
J.J. Weening, Amsterdam, the Netherlands
Sunday, May 16, 2004, 13.30 – 15.00
7. Renal Transplantation.
Chair: C. Newstead, Leeds, United Kingdom and J.L.
Reimão Pinto, Lisbon, Portugal
- Use of altruistic
live donors
K. Baboolal, Cardiff, United Kingdom
- Management of recipients of non-heart beating kidneys
D. Talbot, Newcastle-upon-Tyne, United Kingdom
- Fine-needle aspiration biopsy analysed by flow cytometry – a consistent
and high performance diagnostic tool in kidney transplantation
G. Oliveira, Porto, Portugal
Sunday, May 16, 2004, 13.30 – 15.00
8. Tools for studying renal diseases: new lamps for old?
Chair: J. Floege, Aachen, Germany and S. Sonkodi,
Szeged, Hungary
- Freely associating:
should there be a moratorium on single polymorphism genetic association studies?
F. Luft, Berlin, Germany
- Knowledge based mining or microarray datasets
P. Doran, Dublin, Ireland
- Proteomics – Analysis of proteins in serum and urine by electrophoresis
H. Haller, Hanover, Germany
Sunday, May 16, 2004, 16.00 – 17.30
9. Clinical aspects of inherited disease: from gene to disease.
Chair: G. Friedlander, Paris, France and E. de Almeida,
Lisbon, Portugal
- HNF1 alpha and
beta, two transcription factors involved in renal development and function
L. Gresh, Paris, France
- Dent's disease: Novel insights into the role of chloride channels in the kidney
O. Devuyst, Brussels, Belgium
- Genetics of renal phosphate transport: clinical aspects and pathophysiology
D. Prié, Paris, France
Sunday, May 16, 2004, 16.00 – 17.30
10. Pathogenesis, biology and therapy of renal cancer.
Chair: K.-U. Eckardt, Erlangen, Germany and S. Florquin,
Amsterdam, the Netherlands
- Pathological
activation of the HIF pathway in renal cancer
M. Wiesener, Berlin, Germany
- Renal cancer genetics
E. Maher, Birmingham, United Kingdom
- Clinical management of VHL disease
H. Neumann, Freiburg, Germany
Sunday, May 16, 2004, 16.00 – 17.30
11. Practical approaches to acid-base and fluid-electrolyte disorders.
American Society of Nephrology
Chair: R.G. Narins, Washington, USA and J.C.
Ayus, Houston, USA
- Acid-base case
discussions
R.G. Narins, Washington, USA
- Fluid-electrolyte case discussions
J.C. Ayus, Houston, USA
Monday, May 17, 2004, 09.00 – 10.30
12. A fresh look at the pathogenesis of 2º hyperparathyroidism.
Chair: K. Olgaard, Copenhagen, Denmark and A. Torres,
Tenerife, Spain
- Regulation of
PTH gene expression
J. Silver, Jerusalem, Israel
- Pathogenesis of parathyroid gland hyperplasia
E. Slatopolsky, Saint Louis, USA
- Regulation of PTH secretion by phosphate
M. Rodriguez, Cordoba, Spain
Monday, May 17, 2004, 09.00 – 10.30
13. Glomerulonephritis – breaking new ground in 2004.
Chair: J. Floege, Aachen, Germany and F.C. Neves,
Lisbon, Portugal
- Prognosis and
treatment of Membranous Nephropathy
C. Ponticelli, Milan, Italy
- Focal necrotising glomerulonephritis – from pathogenesis to the clinic
A. Rees, Aberdeen, United Kingdom
- FSGS: recent developments in pathophysiology and treatment
A. Meyrier, Paris, France
Monday, May 17, 2004, 09.00 – 10.30
14. Molecular mechanisms of hypoxia sensing in the kidney.
Chair: K.-U. Eckardt, Erlangen, Germany
- Mechanisms of
oxygen sensing
P. Maxwell, London, United Kingdom
- Hypoxia in acute and chronic renal disease
K.-U. Eckardt, Erlangen, Germany
- Role of hypoxia and angiogenesis in renal development
A. Woolf, London, United Kingdom
Monday, May 17, 2004, 09.00 – 10.30
15. Renal dopamine and hypertension.
Chair: P. Soares da Silva, Porto, Portugal and M. Pestana,
Porto, Portugal
- Intrarenal dopamine:
a key signal in the interactive regulation of sodium metabolism
A. Aperia, Stockholm, Sweden
- G protein-coupled kinase 4 regulation of dopamine receptors in hypertension
P.A. Jose, Washington, USA
- Edema, blood pressure and deficient renal dopamine availability
P. Soares da Silva, Porto, Portugal
Monday, May 17, 2004, 13.30 – 15.00
16. Practice patterns associated with better outcomes for haemodialysis
patients: new results from the DOPPS.
Chair: E.W. Young, Ann Arbor, USA and L. Piera,
Barcelona, Spain
- Introduction
and goals: the DOPPS
- Drug use and risk of morbidity and mortality
E.W. Young, Ann Arbor, USA
- Indicators of mineral metabolism and outcomes
R.N. Greenwood, Stevenage, United Kingdom
- Can vascular access practices be modified to improve outcomes?
C. Combe, Bordeaux, France
- Conclusions: Modifiable practice patterns for better outcomes in haemodialysis
patients
E.W. Young, Ann Arbor, USA
Monday, May 17, 2004, 13.30 – 15.00
17. Clinical Epidemiology in Nephrology.
Chair: C. Zoccali, Reggio Calabria, Italy and C. Wanner,
Würzburg, Germany
- Observational
studies
C. Wanner, Würzburg, Germany
- Prognostic studies in Nephrology: survival analysis and beyond
K. Jager, Amsterdam, the Netherlands
- Diagnostic studies in Nephrology: from design to analysis
C. Zoccali, Reggio Calabria, Italy
Monday, May 17, 2004, 13.30 – 15.00
18. Hypertension: What’s new?
Chair: M. Prata, Lisbon, Portugal and J.L. Rodicio,
Madrid, Spain
- Inflammatory
factors in essential hypertension, renal failure and renal transplant
F. Luft, Berlin, Germany
- The importance of blood pressure control in non-diabetic and diabetic nephropathies
A.B. Ribeiro, São Paulo, Brazil
- Blood pressure control in the dialysis patient
M. Martinez-Maldonado, Ponce, Puerto Rico
Monday, May 17, 2004, 15.30 – 17.00
19. Uraemic Toxicity.
(European Uraemic Toxin Work Group)
Chair: R. Vanholder, Ghent, Belgium and W.H. Hörl,
Vienna, Austria
- New insights
in oxidative stress in uraemic patients
Z. Massy, Amiens, France
- Proteomics applied to explore new areas in uraemic toxicity
E. Weissinger, Hanover, Germany
- Uraemic toxin removal: future ways to go
R. Vanholder, Ghent, Belgium
Monday, May 17, 2004, 15.30 – 17.00
20. Henoch-Schoenlein Purpura Nephritis from childhood to adult age.
Chair: R. Coppo, Turin, Italy and F. Coelho-Rosa,
Lisbon, Portugal
- Comparison of
HSP nephritis in different ages from childhood to old age
R. Coppo, Turin, Italy
- The adult kidney after childhood HSP
M. Nuutinen, Oulu, Finland
- Therapeutical approaches
P. Niaudet, Paris, France
Tuesday, May 18, 2004, 09.00 – 10.30
21. New horizons in IgA Nephropathy?
(International IgA Nephropathy Network)
Chair: J. Feehally, Leicester, United Kingdom and J.G.
Silva, Lisbon, Portugal
- Clinical, biological
and pathological risk factors for progression in IgA nephropathy
F. Berthoux, Saint-Etienne, France
- Role of IgA glycosylation in the development and progression of IgA nephropathy
A. Amore, Turin, Italy
- Treatment options in IgA nephropathy
J. Feehally, Leicester, United Kingdom
Tuesday, May 18, 2004, 09.00 – 10.30
22. Current immunosuppression regimes after renal transplantation: the
way forward.
Chair: S. Schwartz Sorensen, Copenhagen, Denmark and D.
Machado, Lisbon, Portugal
- Long-term beneficial
effects of Mycophenolate mofetil in renal transplant patients
J.M. Grinyo, Barcelona, Spain
- Long-term results using Rapamycin after renal transplantation
F.P. Schena, Bari, Italy
- Optimization of immunosupression in critical recipients populations
U. Frei, Berlin, Germany
Tuesday, May 18, 2004, 09.00 – 10.30
23. Inflammation in haemodialysis: surveying the terrain.
Chair: P. Aljama, Cordoba, Spain and I.C. Macdougall,
London, United Kingdom
- Cellular mechanisms
of inflammation in haemodialysis
P. Aljama, Cordoba, Spain
- Clinical relevance and consequences of dialysis related inflammation
P. Stenvinkel, Stockholm, Sweden
- How to prevent and treat the inflammatory state in dialysis patients
C. Wanner, Würzburg, Germany
Tuesday, May 18, 2004, 09.00 – 10.30
24. Moving towards a more physiological dialysis: the relevance of time
and frequency factors.
Chair: A.L.M. de Francisco, Santander, Spain and J.
Vinhas, Setúbal, Portugal
- Is it possible
to control arterial hypertension with conventional haemodialysis?
A.L.M. de Francisco, Santander, Spain
- The importance of time and frequency on dialysis morbidity and mortality
N. Lameire, Ghent, Belgium
- Home haemodialysis revisited
M.P. Kooistra, Utrecht, the Netherlands
Tuesday, May 18, 2004, 11.00 – 12.30
25. Hypertension and cardiovascular risk in nephrology: what’s
next?
Chair: G. London, Fleury-Merogis, France and S. Mezzano,
Valdivia, Chile
- Barker-Brenner
hypothesis of essential hypertension: coming of age?
K. Amann, Erlangen, Germany
- How to measure blood pressure and arterial function in patients with CRF
G. London, Fleury-Merogis, France
- Are biomarkers useful for risk stratification in patients with CRF?
F. Mallamaci, Reggio Calabria, Italy
Tuesday, May 18, 2004, 11.00 – 12.30
26. Long-term complications after renal transplantation.
Chair: J.M. Morales, Madrid, Spain and A.M. Sarmento,
Porto, Portugal
- Management of
cardiovascular risk factors
J.M. Campistol, Barcelona, Spain
- Management of patients with neoplasia
B. Watschinger, Vienna, Austria
- Management of hepatitis C virus infection
J.M. Morales, Madrid, Spain
Tuesday, May 18, 2004, 11.00 – 12.30
27. Quality assurance process to improve dialysis outcomes.
Chair: B. Canaud, Montpellier, France and A. Ferreira,
Lisbon, Portugal
- Continuous quality
improvement process in dialysis adequacy delivery: How to implement it in a
dialysis facility
B. Canaud, Montpellier, France
- Blood volume control and blood pressure control in HD. How to use UF, Na modelling
and biofeedback devices to optimise restoration of volemia and correction of
blood pressure
A. Santoro, Bologna, Italy
- How the computer can help the clinician in achieving dialysis adequacy
J. Tattersall, Leeds, United Kingdom
Tuesday, May 18, 2004, 11.00 – 12.30
28. Water Metabolism.
Chair: P. Gross, Dresden, Germany and N. Schor,
São Paulo, Brazil
- The roles of
aquaporin-2 in water losing and water retention states of the kidney
S. Nielsen, Aarhus, Denmark
- The human V2 vasopressin receptor: the gene, the protein, the mutations and
rescue strategies of mutant receptors
W. Rosenthal, Berlin, Germany
- The treatment of hyponatremia using oral vasopressin antagonists
P. Gross, Dresden, Germany
Sunday,
May 16, 2004, 10.30 - 12.00
ERA-EDTA Registry Report.
Chair: C. Zoccali, Reggio Calabria, Italy and F. Locatelli,
Lecco, Italy
- The challenges
of the ERA-EDTA Registry
C. Zoccali, Reggio Calabria, Italy
- ERA-EDTA Registry Report 2004
K. Jager, Amsterdam, the Netherlands
- Co-morbidity and access to renal transplantation
V. Stel, Amsterdam, the Netherlands
- Co-morbidity and patient survival on RRT
J. van Manen, Amsterdam, the Netherlands
- Mortality in the general population and its relationship with RRT
P. van Dijk, Amsterdam, the Netherlands
- Paediatric RRT
J. Tizard, Bristol, United Kingdom
Sunday,
May 16, 2004, 15.00 - 16.00
European Best Practice Guidelines
Anaemia.
Chair: F. Locatelli, Lecco, Italy and F. Carrera,
Lisbon, Portugal
- Guidelines in
European Nephrology: from the beginning to 2004
J.S. Cameron, London, United Kingdom
- Kidney Disease: Improving Global Outcomes
G. Eknoyan, Houston, USA
- The European Best Practice Guidelines from 1999 to 2004: what is new?
F. Locatelli, Lecco, Italy
Monday,
May 17, 2004, 15.30 - 17.40
Kidney International Forum
Vascular injury mediated by calcineurin inhibitors.
Chair: J.T. Harrington, Boston, USA
Principal discussant: S. Lamas, Madrid, Spain
Saturday,
May 15, 2004, 09.00 - 17.30
European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) in collaboration with Sociedad Latino Americana de Nefrologia e Hipertension (SLANH)
Scientific
Committee
F. Carrera, Lisbon, Portugal
J.M. Cruz, Valencia, Spain
S. Mezzano, Valdivia, Chile
J. Cannata-Andía, Oviedo, Spain
Programme
Inauguración
F. Carrera, Lisboa, Portugal
Moderadores: A.L.M. De Francisco, Santander, España y J. Vinhas, Setubal, Portugal
Avanços em Biologia Celular e Molecular na IRA
N. Schor, São Paulo, Brasil
Actualização
em nefrotoxicidade por drogas
E. Burdmann, São Jose de Rio Preto, Brasil
Nefropatía
diabética: una cuestión de inflamación?
J. Navarro, Tenerife, España
Moderadores: M. Martinez-Maldonado, Puerto Rico y M. Riella, Curitiba, Brasil
Síndrome nefrótico: nuevos conceptos sobre una antigua enfermedad
S. Mezzano, Valdivia, Chile
Hipertensión
sistolica: reflexiones sobre un caso de Giovanni Battista Morgani (1769)
B. Rodríguez-Iturbe, Maracaibo, Venezuela
Prevención de la progresión de la lesión renal y del riesgo
cardiovascular en la enfermedad renal crónica
J. Luño, Madrid, España
Moderadores: J.C. Ayus, Houston, USA y A.M. Sarmento,
Porto, Portugal
Prevención del desarrollo y progresión de la Nefropatía
Diabética
R. Correa-Rotter, Ciudad México, México
DOPPS: una buena
herramienta para mejorar el tratamiento con hemodiálisis
J.M. Cruz, Valencia, Spain
Substituição da função renal em doentes HIV+
M.J. Pais, Lisboa, Portugal
Alteraciones en
el perfil lipídico: un importante factor de riesgo en el Trasplante Renal
I. Beneyto, España
Clausura
J. Cannata-Andía, Oviedo, Spain
IMPORTANT!
You can register
for the Iberoamerican Course by sending your request to the ERA-EDTA Congress
Office, e-mail: congress@era-edta.org
by April 11.
Participation in the courses is free of charge, but there is a limited number
of seats, thus we kindly ask you to register only if you are sure that you will
be able to participate. Registration is mandatory, and should the course prove
to be over-subscribed, we shall confirm registrations on a "first come
first served" basis.
If there are any free places remaining, on-site registration will be available
on May 15 from 8.00 o’clock onward at the Renal Pathology/IberoAmerican
courses desk located in the Lisbon Congress Centre.
Saturday, May 15, 2004, 09.00 – 17.30
European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) in collaboration with International Society of Nephrology (ISN) and Renal Pathology Society (RPS)
Scientific
Committee
J.A. Bruijn, Leiden, the Netherlands
T. Cook, London, United Kingdom
F. Ferrario, Milan, Italy
J.J. Weening, Amsterdam, the Netherlands
Programme
Current
dilemmas in diagnostic renal pathology: morphological features and case presentation
Chair: J.A. Bruijn, Leiden, the Netherlands and J.J.
Weening, Amsterdam, the Netherlands
Focal Segmental
Glomerulosclerosis
L.H. Noel, Paris, France
Membranoproliferative
Glomerulonephritis
S. Florquin, Amsterdam, the Netherlands
ANCA – Associated
Vasculitis
F. Ferrario, Milan, Italy
Lupus Nephritis
T. Cook, London, United Kingdom
Thrombotic Microangiopathy
A. Fogo, Nashville, USA
Renal Transplant
Rejection
I. Bajema, Leiden, the Netherlands
IMPORTANT!
You can register
for the Iberoamerican Course by sending your request to the ERA-EDTA Congress
Office, e-mail: congress@era-edta.org
by April 11.
Participation in the courses is free of charge, but there is a limited number
of seats, thus we kindly ask you to register only if you are sure that you will
be able to participate. Registration is mandatory, and should the course prove
to be over-subscribed, we shall confirm registrations on a "first come
first served" basis.
If there are any free places remaining, on-site registration will be available
on May 15 from 8.00 o’clock onward at the Renal Pathology/IberoAmerican
courses desk located in the Lisbon Congress Centre.